Biogen Provides Regulatory Update on the Supplemental Biologic License Application (sBLA) for …
CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) f …
Discussion disabled.
Category: Dementia